6-K

UBS AG (AMUB)

6-K 2025-05-08 For: 2025-03-30
View Original
Added on April 06, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

FORM 6-K

REPORT OF FOREIGN PRIVATE

ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

Date: May 8, 2025

UBS Group AG

(Registrant's

Name)

Bahnhofstrasse 45, 8001 Zurich, Switzerland

(Address of principal executive office)

Commission File Number: 1-36764

UBS AG

(Registrant's

Name)

Bahnhofstrasse 45, 8001 Zurich, Switzerland

Aeschenvorstadt 1, 4051 Basel, Switzerland

(Address of principal executive offices)

Commission File Number: 1-15060

Indicate by check mark whether the registrants file or will file annual

reports under cover of Form 20-F or Form

40-

F.

Form 20-F

Form 40-F

This Form 6-K consists of UBS supplementary information

for significant regulated subsidiaries and sub-groups

for

the first quarter of 2025, which appear immediately following this page.

edgar00significantregp3i0

UBS Group significant

regulated subsidiary

and sub-group information

First quarter

2025

Significant regulated subsidiary and sub-group

information

3

Significant regulated subsidiary

and sub-group information

Unaudited

Financial and regulatory key figures for our significant regulated

subsidiaries and sub-groups

UBS AG

(consolidated)

UBS AG

(standalone)

UBS Switzerland AG

(standalone)

UBS Europe SE

(consolidated)

UBS Americas

Holding LLC

(consolidated)

All values in million, except where indicated

USD

USD

CHF

EUR

USD

Financial and regulatory requirements

IFRS Accounting Standards

Swiss SRB rules

IFRS Accounting

Standards

Swiss SRB rules

IFRS Accounting

Standards

Swiss SRB rules

IFRS Accounting

Standards

EU regulatory rules

US GAAP

US Basel III rules

As of or for the quarter ended

31.3.25

31.12.24

31.3.25

31.12.24

31.3.25

31.12.24

31.3.25

31.12.24

1

31.3.25

31.12.24

2

Financial information

3

Income statement

Total operating income

4

12,040

11,076

3,956

4,884

3,215

2,941

347

316

4,567

4,392

Total operating expenses

10,701

11,017

3,521

3,823

2,419

2,478

310

289

4,348

4,205

Operating profit / (loss) before tax

1,339

59

434

1,060

796

464

37

27

219

187

Net profit / (loss)

1,035

(254)

409

1,025

663

372

30

21

331

249

Balance sheet

Total assets

1,547,489

1,568,060

938,573

966,697

518,544

526,521

54,463

55,344

210,803

211,893

Total liabilities

1,450,367

1,473,394

848,944

878,365

491,592

500,273

49,858

50,966

183,825

185,168

Total equity

97,123

94,666

89,629

88,332

26,952

26,249

4,605

4,377

26,978

26,725

Capital

5

Common equity tier 1 capital

70,756

73,792

70,980

75,051

21,596

21,659

3,424

3,239

16,236

16,123

Additional tier 1 capital

18,325

15,830

18,325

15,830

7,995

7,994

600

600

2,817

2,818

Total going concern capital / Tier 1 capital

89,081

89,623

89,305

90,881

29,590

29,652

4,024

3,839

19,053

18,941

Tier 2 capital

205

207

204

204

205

240

Total capital

4,024

3,839

19,258

19,181

Total gone concern loss-absorbing capacity

93,705

92,177

93,703

92,174

19,248

19,274

2,527

6

2,540

6

7,800

7

7,800

7

Total loss-absorbing capacity

182,786

181,800

183,009

183,055

48,838

48,926

6,551

6,379

26,853

7

26,741

7

Risk-weighted assets and leverage

ratio denominator

5

Risk-weighted assets

481,539

495,110

514,897

507,964

174,610

186,265

14,474

14,079

79,345

78,585

Leverage ratio denominator

1,565,845

1,523,277

935,496

899,348

551,716

556,053

55,593

55,676

204,960

197,487

Supplementary leverage ratio denominator

234,346

227,973

Capital and leverage ratios (%)

5

Common equity tier 1 capital ratio

14.7

14.9

13.8

14.8

12.4

11.6

23.7

23.0

20.5

20.5

Going concern capital ratio / Tier 1 capital ratio

18.5

18.1

17.3

17.9

16.9

15.9

27.8

27.3

24.0

24.1

Total capital ratio

27.8

27.3

24.3

24.4

Total loss-absorbing capacity ratio

38.0

36.7

28.0

26.3

45.3

45.3

33.8

34.0

Tier 1 leverage ratio

7.2

6.9

9.3

9.6

Supplementary tier 1 leverage ratio

8.1

8.3

Going concern leverage ratio

5.7

5.9

9.5

10.1

5.4

5.3

Total loss-absorbing capacity leverage ratio

11.7

11.9

8.9

8.8

11.8

11.5

13.1

13.5

Gone concern capital coverage ratio

125.1

122.3

Liquidity coverage ratio

5

High-quality liquid assets (bn)

318.9

331.6

150.5

142.7

111.2

125.0

18.7

17.3

28.2

26.8

Net cash outflows (bn)

176.9

178.2

66.0

58.6

81.2

87.2

13.4

12.5

21.2

20.1

Liquidity coverage ratio (%)

180.3

186.1

229.2

8

244.0

137.1

9

143.5

140.4

138.9

132.9

133.6

Net stable funding ratio

5

Total available stable funding (bn)

853.7

847.0

410.5

410.2

355.0

359.2

18.6

17.1

107.9

109.3

Total required stable funding (bn)

695.2

682.5

418.7

421.8

276.3

271.7

13.2

13.7

80.5

80.5

Net stable funding ratio (%)

122.8

124.1

98.1

10

97.3

128.5

10

132.2

140.5

125.5

134.0

135.8

Other

Joint and several liability between UBS AG and

UBS Switzerland AG (bn)

11

3

3

1 Comparative figures have been restated to align

with the regulatory reports as submitted to the European

Central Bank (the ECB).

2 The 2024 financial and regulatory

information for UBS Americas Holding LLC

is inclusive of Credit Suisse Holdings (USA), Inc. following the reparenting

of this entity under UBS Americas Holding LLC on 7 June

2024.

3 The financial information disclosed does not represent a full set of financial

statements under the respective GAAP / IFRS Accounting Standards.

4 The total operating income includes credit loss expense

or release.

5 Refer to the UBS Group and significant regulated subsidiaries and sub-

groups 31 March 2025

Pillar 3 Report, available

under “Pillar 3

disclosures” at ubs.com/investors,

for more information.

6 Consists of positions

that meet the

conditions laid down

in Art. 72a–b of

the Capital

Requirements Regulation II with regard to contractual, structural or legal subordination.

7 Consists of eligible long-term debt that meets the conditions specified in 12 CFR § 252.162 of the final total loss-absorbing

capacity (TLAC) rules.

TLAC is the

sum of tier 1

capital and eligible

long-term debt.

8 In the first

quarter of 2025,

the liquidity coverage

ratio (the LCR)

of UBS AG was

229.2%, remaining above

the prudential

requirements communicated by FINMA.

9 In the first quarter of 2025, the LCR of

UBS Switzerland AG, which is a

Swiss SRB, was 137.1%, remaining

above the prudential requirement communicated by FINMA

in

connection with the Swiss Emergency Plan.

10 In accordance with Art. 17h para. 3 and 4 of the Liquidity Ordinance, UBS AG standalone is required to maintain a minimum NSFR of at least 80% without taking into

account excess funding of UBS Switzerland AG and 100% after taking into account such excess funding.

11 Under certain circumstances, the Swiss Banking Act and FINMA’s Banking Insolvency Ordinance authorize

FINMA to modify, extinguish

or convert to common equity liabilities

of a bank in connection with

a resolution or insolvency of

such bank. As of 31 March

2025, the amount consists of a

joint and several liability of

UBS Switzerland AG for contractual obligations of UBS AG related to the establishment of UBS Switzerland AG (CHF 2.3bn), and a joint and several

liability of UBS Switzerland AG in connection with the international

covered bonds program of UBS AG (CHF 0.5bn) which was fully collateralized through cash deposits

from UBS AG.

Significant regulated subsidiary and sub-group

information

4

UBS Group AG

is

a

holding

company

and

conducts

substantially

all

of

its

operations

through

UBS AG

and

subsidiaries thereof. UBS Group AG and

UBS AG have contributed a

significant portion of

their respective capital

to,

and

provide

substantial

liquidity

to,

such

subsidiaries.

Many

of

these

subsidiaries

are

subject

to

regulations

requiring compliance

with minimum

capital, liquidity

and similar requirements.

The tables in

this section summarize

the

regulatory

capital

components

and

capital

ratios

of

our

significant

regulated

subsidiaries

and

sub-groups

determined under the regulatory framework of

each subsidiary’s or sub-group’s home

jurisdiction.

Supervisory authorities generally have discretion to impose higher requirements or

to otherwise limit the activities

of subsidiaries. Supervisory

authorities also may

require entities to

measure capital

and leverage ratios

on a stressed

basis and may limit

the ability of

an entity to engage

in new activities or

take capital actions

based on the results

of

those tests.

In August 2024, the Federal Reserve

Board assigned UBS Americas Holding LLC a stress

capital buffer (an SCB) of

9.3%

as

of

1 October

2024

(previously

9.1%)

under

the

Federal

Reserve

Board’s

SCB

rule,

resulting

in

a

total

common equity tier 1 capital

requirement of 13.8%. The

SCB for our

US-based intermediate holding company is

based on the previously

released results of the Federal

Reserve Board’s 2024 Dodd–Frank Act Stress

Test (DFAST),

where UBS Americas

Holding LLC exceeded

the minimum

capital requirements

under the severely

adverse scenario.

Additional information

on the

above entities

is provided

in the

UBS Group

and significant

regulated subsidiaries

and sub-groups 31 March 2025 Pillar 3 Report,

available under “Pillar 3 disclosures” at

ubs.com/investors

.

Credit Suisse International

(standalone)

All values in million, except where indicated

USD

Financial and regulatory requirements

IFRS Accounting Standards

UK regulatory rules

As of or for the quarter ended

31.3.25

31.12.24

Financial information

1

Income statement

Total operating income

2

44

104

Total operating expenses

152

164

Operating profit / (loss) before tax

(108)

(60)

Net profit / (loss)

(92)

(124)

Balance sheet

Total assets

34,030

51,374

Total liabilities

26,783

44,035

Total equity

7,247

7,339

Capital

3

Common equity tier 1 capital

6,816

6,883

Additional tier 1 capital

0

0

Total going concern capital / Tier 1 capital

6,816

6,883

Tier 2 capital

0

0

Total capital

6,816

6,883

Total gone concern loss-absorbing capacity

0

3,043

Total loss-absorbing capacity

6,816

9,926

Risk-weighted assets and leverage ratio

denominator

3

Risk-weighted assets

9,332

10,951

Leverage ratio denominator

23,341

32,521

Capital and leverage ratios (%)

3

Common equity tier 1 capital ratio

73.0

62.9

Going concern capital ratio / Tier 1 capital ratio

73.0

62.9

Total capital ratio

73.0

62.9

Total loss-absorbing capacity ratio

73.0

90.6

Tier 1 leverage ratio

29.2

21.2

Going concern leverage ratio

Total loss-absorbing capacity leverage ratio

29.2

30.5

Liquidity coverage ratio

3

High-quality liquid assets (bn)

14.0

15.0

Net cash outflows (bn)

4.1

4.3

Liquidity coverage ratio (%)

361.8

363.3

Net stable funding ratio

3

Total available stable funding (bn)

14.0

17.5

Total required stable funding (bn)

6.1

8.7

Net stable funding ratio (%)

241.8

214.8

1 The financial information disclosed does not represent a full set of financial statements under the

respective GAAP / IFRS Accounting Standards.

2 The total operating income includes credit loss expense or release.

3 Refer to the UBS Group and significant regulated subsidiaries and sub-groups 31 March 2025 Pillar 3 Report, available under “Pillar 3 disclosures”

at ubs.com/investors, for more information.

edgar00significantregp6i0

UBS Group AG

PO Box

CH-8098 Zurich

ubs.com

This

Form

6-K

is

hereby

incorporated

by

reference

into

(1)

each

of

the

registration

statements

on

Form

F-3

(Registration Number

333-283672), and

on Form

S-8 (Registration

Numbers 333-200634;

333-200635; 333-200641;

333-200665;

333-215254;

333-215255;

333-228653;

333-230312;

333-249143

and

333-272975),

and

into

each

prospectus outstanding

under any

of the

foregoing registration

statements, (2)

any outstanding

offering circular

or

similar document issued

or authorized by

UBS AG that

incorporates by reference

any Forms 6-K

of UBS AG

that

are incorporated into

its registration statements filed

with the SEC,

and (3) the

base prospectus of

Corporate Asset

Backed Corporation (“CABCO”)

dated June 23, 2004

(Registration Number 333-111572), the Form

8-K of CABCO

filed and

dated June

23, 2004

(SEC File

Number 001-13444),

and the

Prospectus Supplements

relating to

the CABCO

Series 2004-101 Trust dated May 10, 2004 and May 17, 2004 (Registration

Number 033-91744 and 033-91744-05).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the

registrants have duly caused this

report to be signed on their behalf by the undersigned, thereunto duly

authorized.

UBS Group AG

By:_/s/ David Kelly_____________

Name:

David Kelly

Title:

Managing Director

By:_/s/ Ella Copetti-Campi_____________

Name:

Ella Copetti-Campi

Title:

Executive Director

UBS AG

By:_/s/ David Kelly_____________

Name:

David Kelly

Title:

Managing Director

By:_/s/ Ella Copetti-Campi_____________

Name:

Ella Copetti-Campi

Title:

Executive Director

Date:

May 8, 2025